DK3434276T3 - Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft - Google Patents
Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft Download PDFInfo
- Publication number
- DK3434276T3 DK3434276T3 DK18192533.0T DK18192533T DK3434276T3 DK 3434276 T3 DK3434276 T3 DK 3434276T3 DK 18192533 T DK18192533 T DK 18192533T DK 3434276 T3 DK3434276 T3 DK 3434276T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305636 | 2012-06-06 | ||
| EP13730146.1A EP2858660B1 (en) | 2012-06-06 | 2013-06-06 | Method and pharmaceutical composition for use in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3434276T3 true DK3434276T3 (da) | 2025-01-20 |
Family
ID=48669879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18192533.0T DK3434276T3 (da) | 2012-06-06 | 2013-06-06 | Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9198949B2 (forum.php) |
| EP (2) | EP2858660B1 (forum.php) |
| JP (2) | JP2015520178A (forum.php) |
| CN (1) | CN104519898A (forum.php) |
| DK (1) | DK3434276T3 (forum.php) |
| ES (1) | ES3009438T3 (forum.php) |
| IN (1) | IN2014DN09963A (forum.php) |
| WO (1) | WO2013182650A1 (forum.php) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014160183A1 (en) * | 2013-03-13 | 2014-10-02 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Methods for modulating chemotherapeutic cytotoxicity |
| EP3454879B1 (en) * | 2016-05-10 | 2021-12-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New compounds and pharmaceutical use thereof in the treatment of cancer |
| EP3243522A1 (en) * | 2016-05-10 | 2017-11-15 | Université Pierre et Marie Curie (Paris 6) | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death |
| JP7537074B2 (ja) * | 2016-05-10 | 2024-08-21 | ソルボンヌ ウニベルシテ | Ｃｄ４７を活性化する作用物質およびその炎症治療における使用 |
| CN107703109B (zh) * | 2016-08-08 | 2021-01-15 | 华东理工大学 | 二维硫化钼多肽复合材料及其在靶向cd47癌症标记中的应用 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| EP3650036A1 (en) | 2018-11-06 | 2020-05-13 | Sorbonne Universite | Synthetic peptides inducing immunogenic cell death |
| US20220160812A1 (en) * | 2019-05-22 | 2022-05-26 | Cytopharma Gmbh | A pharmaceutically active substance |
| CN116726188A (zh) * | 2022-11-29 | 2023-09-12 | 浙江大学杭州国际科创中心 | 一种靶向cd47蛋白的纳米焦亡药物及其制备和应用 |
| CN116831988A (zh) * | 2023-06-13 | 2023-10-03 | 南京鼓楼医院 | 一种载肽模拟物pkhb1的脂质体眼用制剂及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU643427B2 (en) | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
| WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| JPH0853494A (ja) * | 1994-06-07 | 1996-02-27 | Nihon Medi Physics Co Ltd | 腫瘍親和性ペプチド、該ペプチドを含有してなる放射性診断剤および放射性治療剤 |
| AU684348B2 (en) | 1994-06-07 | 1997-12-11 | Nihon Medi-Physics Co., Ltd. | Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide |
| US5610271A (en) * | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
| US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
| ES2258798T3 (es) * | 1996-11-27 | 2006-09-01 | Boston Heart Foundation, Inc. | Nuevas proteinas de union a hipoproteinas de baja densidad y su uso para el diagnostico y el tratamiento de la arterosclerosis. |
| US6579520B2 (en) | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| EP1283850A2 (en) | 2000-05-26 | 2003-02-19 | Beth Israel Deaconess Medical Center | Thrombospondin type 1 repeat polypeptides |
| US20060188508A1 (en) * | 2005-02-17 | 2006-08-24 | Cohen Stanley N | Methods and compositions for modulating angiogenesis |
| JP2009013142A (ja) * | 2007-07-09 | 2009-01-22 | Kyoto Univ | 徐放用メソポーラスシリカ |
| JP5661988B2 (ja) * | 2008-02-26 | 2015-01-28 | 株式会社ペプタイドドア | ムスカリンレセプター活性化剤及びペプチド |
-
2013
- 2013-06-06 WO PCT/EP2013/061727 patent/WO2013182650A1/en active Application Filing
- 2013-06-06 EP EP13730146.1A patent/EP2858660B1/en not_active Not-in-force
- 2013-06-06 CN CN201380029870.5A patent/CN104519898A/zh active Pending
- 2013-06-06 EP EP18192533.0A patent/EP3434276B1/en active Active
- 2013-06-06 IN IN9963DEN2014 patent/IN2014DN09963A/en unknown
- 2013-06-06 US US14/406,091 patent/US9198949B2/en active Active
- 2013-06-06 JP JP2015515526A patent/JP2015520178A/ja active Pending
- 2013-06-06 DK DK18192533.0T patent/DK3434276T3/da active
- 2013-06-06 ES ES18192533T patent/ES3009438T3/es active Active
-
2015
- 2015-10-05 US US14/874,657 patent/US20160039908A1/en not_active Abandoned
-
2017
- 2017-08-28 US US15/687,692 patent/US20170362302A1/en not_active Abandoned
- 2017-11-22 JP JP2017224767A patent/JP2018057394A/ja active Pending
-
2018
- 2018-10-16 US US16/161,931 patent/US10759843B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9198949B2 (en) | 2015-12-01 |
| US20150126456A1 (en) | 2015-05-07 |
| US20160039908A1 (en) | 2016-02-11 |
| ES3009438T3 (en) | 2025-03-26 |
| EP2858660A1 (en) | 2015-04-15 |
| WO2013182650A1 (en) | 2013-12-12 |
| JP2018057394A (ja) | 2018-04-12 |
| US20190135898A1 (en) | 2019-05-09 |
| US20170362302A1 (en) | 2017-12-21 |
| EP3434276B1 (en) | 2024-10-30 |
| EP2858660B1 (en) | 2018-09-05 |
| CN104519898A (zh) | 2015-04-15 |
| IN2014DN09963A (forum.php) | 2015-08-14 |
| US10759843B2 (en) | 2020-09-01 |
| EP3434276A1 (en) | 2019-01-30 |
| JP2015520178A (ja) | 2015-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2818481T3 (da) | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer | |
| DK3444342T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme | |
| DK3838923T3 (da) | Antistoffer og vacciner til anvendelse ved behandling af ror1-cancere og hæmning af metastase | |
| DK2532366T3 (da) | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer | |
| DK3035955T3 (da) | Sammensætning og vaccine til behandling af lungekræft | |
| DK3434276T3 (da) | Fremgangsmåde og farmaceutisk sammensætning til anvendelse i behandlingen af kræft | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| BR112015000437A2 (pt) | imunoconjugados, formulação farmacêutica, métodos de tratamento e de inbir a proliferação de uma célula | |
| DK2815769T3 (da) | Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet | |
| DK2898061T3 (da) | Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande | |
| DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
| DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
| DK3351630T3 (da) | Farmaceutisk sammensætning omfattende anti caprin-1-antistoffer til behandling og/eller forebyggelse af cancer | |
| DK2861584T3 (da) | Pyridopyrazin- og naphthyridinderivater til behandling af cancer | |
| DK3035849T3 (da) | Lægemiddeleluering til beskyttelse in vivo af biosensor-analysander | |
| DK2941258T3 (da) | Sammensætninger og fremgangsmåder til behandling af cancer ved anvendelse af bakterier | |
| DK3088353T3 (da) | Bilirubinpartikler og deres fremstilling til anvendelse i terapi | |
| DK3049056T3 (da) | Topisk antisvampesammensætning og fremgangsmåder til behandling | |
| DK3269386T3 (da) | Aluminiumforbindelser til anvendelse inden for behandling og i vacciner | |
| IL235923A0 (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof | |
| DK3366307T3 (da) | Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri | |
| DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
| DK2830654T3 (da) | Metoder og sammensætninger til behandling af inflammation | |
| DK2914630T3 (da) | Hidtil ukendte antigen-bindende proteiner og deres anvendelse som adresseringsprodukt til behandling af kræft |